ReviewExperimental and therapeutic medicine2022

Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review).

Liliana Baroiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.